chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm swelled up; Very hard sore; Itchy at the site; Redness; Very rough; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Very hard sore), VACCINATION SITE PRURITUS (Itchy at the site), ERYTHEMA (Redness) and DRY SKIN (Very rough) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LETROZOLE, FISH OIL, CENTRUM SILVER +50 and VITAMIN D3.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Very hard sore), VACCINATION SITE PRURITUS (Itchy at the site), ERYTHEMA (Redness), DRY SKIN (Very rough) and FATIGUE (Fatigue). At the time of the report, PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Very hard sore), VACCINATION SITE PRURITUS (Itchy at the site), ERYTHEMA (Redness), DRY SKIN (Very rough) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: No specific follow-up information recorded.
On either side of his neck, h e got a red (not quite a rash) - it was not bumpy (like eczema) but patchy red. Lymph nodes were swollen on neck underneath those red patches. Itchy - On that Sunday, when I noticed it, the Pharmacist said to take: Oral Benadryl and topical Benadryl for adverse reaction.  We did that for a week and it started to go away. I outlined the rash with sharpie  - t did get bigger and started spreading down his shoulders. As of today, it's cleared up - you can see a dark mark where it was but it's fading away.
Patient had a little swelling at injection site, Pt had previously already received the one vaccine needed after 65 but pharmacist missed that the patient had received it and revaccinated patient.  This was the second dose within the year.
patient received a second dose of Prevnar 3 months after his first. he told the pharmacy he had received a flu shot in February
7MAR91 recvd Engerix-B & on 8MAR91 exp general achiness & a sore on lip ("like a fever blister"); No treatment has been reported;
Pt developed a severe allergic reaction characterized by fever, flu like symptoms, shakes, dizziness, hives, redness and swelling at the injection site. Pt was seen in the ER and treated with steroids and epinephrine. This event is considered medically important.
PVAX85 (M,61-65 years old) did not respond significantly to any of the tested streotypes; This spontaneous report was received from a non-peer reviewed article referring to a female patient aged from 71 to 75. The patient was not vaccinated with any pneumococcal vaccines before and no history of previous pneumonia. The patient's medical history, historical drugs, concurrent conditions, and concomitant drugs were not reported.   On an unknown date (reported as "during the 2017 and 2018 seasons"), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX) injection (strength, dose, route of administration, anatomical location, lot#, and expiration date were not reported) to prevent pneumococcal infections.  The patient did not respond significantly to any of the tested stereotypes (therapy non-responder). The outcome of the event, and the causal relationship between therapy non-responder and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX) were not reported.    This case was received from the same reporter with 2305USA002183, 2305USA003458, and 2305USA003460.
Patient received the second HPV vaccine and within 30 seconds had syncopal episode. Regained consciousness within 10 seconds. Complained of dizziness and could not recall event. Vitals were taken and normal. Given apple juice and observed until feeling well about 20 minutes. This was patient's first visit to this clinic and after syncopal episode mother disclosed that he fainted when he received shots before but could not recall which vaccines he received at that time.
This spontaneous report was received from a Licensed Vocational Nurse (L.V.N.) referring to a 15 month old patient. The patient's medical history and concurrent condition were not reported. On 07-APR-2016, the patient was inadvertently vaccinated with GARDASIL 9 lot # L020015; expiration date 16-AUG-2017 (dose and route of administration were not reported) instead of an intended dose of LIQUID PEDVAXHIB (Lot#, expiration date, dose and route of administration were not reported). Concomitant medication was not reported. The nurse reported that hpv was confused with LIQUID PEDVAXHIB, although she did not know the specific reason why the confusion occurred. LIQUID PEDVAXHIB was not administered. No adverse effect reported. Additional information has been requested.
facial and feet tingling; dulled sensation to her left ankle down around her left foot as well as in her lower abdomen; muscle spasms; swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (facial and feet tingling), HYPOAESTHESIA (dulled sensation to her left ankle down around her left foot as well as in her lower abdomen), MUSCLE SPASMS (muscle spasms) and LYMPHADENOPATHY (swollen lymph nodes) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 008B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced PARAESTHESIA (facial and feet tingling), HYPOAESTHESIA (dulled sensation to her left ankle down around her left foot as well as in her lower abdomen), MUSCLE SPASMS (muscle spasms) and LYMPHADENOPATHY (swollen lymph nodes). At the time of the report, PARAESTHESIA (facial and feet tingling) had resolved, HYPOAESTHESIA (dulled sensation to her left ankle down around her left foot as well as in her lower abdomen) and MUSCLE SPASMS (muscle spasms) outcome was unknown and LYMPHADENOPATHY (swollen lymph nodes) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment and concomitant medicines were  not reported  Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to MOD-2021-101643 (Patient Link).
immediate redness at injection site which spread to entire posterior arm and down unilateral back in continuous distribution. Well demarcated borders down the unilateral back. Some heaviness and soreness of the arm, mild warmth and swelling. No fevers, chills.  Completely resolved after 1-2 days , took 1 dose benadryl
received the second dose after 43 days; punching on arm lasted for 36 hours; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (received the second dose after 43 days) and LIMB DISCOMFORT (punching on arm lasted for 36 hours) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included Guillain-Barre syndrome and Pacemaker insertion (cardiac). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN) for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (received the second dose after 43 days) and LIMB DISCOMFORT (punching on arm lasted for 36 hours). At the time of the report, PRODUCT DOSE OMISSION ISSUE (received the second dose after 43 days) and LIMB DISCOMFORT (punching on arm lasted for 36 hours) outcome was unknown.            This case was linked to MOD-2021-063990 (Patient Link).
Swollen tongue; rash on arms, waist, back, to under eyes 28FEB; All sx subsided x/rash; 2nd dose of vax 26MAR91; 27MAR nausea, rash worsened, mouth ulcers, tongue "burning", weight loss of 15 lbs fr time of 2nd dose until present;
since the first vaccine I'm awaken with horrible headaches some times I feel Like my Head is going to explode. If I get a headache later in the day it comes with nausea wanting to vomit.
3x4 cm area reddness @ inject site; 8cm induration-swelling , warm to touch;
Pfizer vaccine was administered outside of Facility- reported by patient- ? NO LOT NUMBER WERE SUPPLIED -------------------------------------------------------------------------------------------------------------------------------- J96.00 ACUTE RESPIRATORY FAILURE 12/18/2021 NONTRAUMATIC ACUTE KIDNEY INJURY R09.02 HYPOXIA 12/18/2021 NONTRAUMATIC ACUTE KIDNEY INJURY
Client received vaccine at 9:35am. Client was immediately syncopal and fell and hit head on floor. RN who administered vaccine noted possible brief tonic clonic activity during syncope. Patient pale and sweating. Client awoke within seconds after fall and was panicked and trying to stand back up. RNs reassured patient and helped patient back into safe lying position. Legs were elevated, VS assessed, ice applied to back of head. No bleeding noted. When patient felt ready and was alert/oriented, nurse raised patient to sitting position and moved into wheelchair. Patient still pale and sweating. Lead RN called EMS due to concern for potential head injury with fall. Patient states that he is lightheaded again and loses consciousness again in wheelchair as RN and EMT are wheeling patient out to be received by EMS squad. EMT supporting patient airway during second LOC - RN notes that airway support (with EMT hands) may be too tight as patient red faced and some throat gurgling. EMT adjusts grip. Patient regains consciousness within 1-2 minutes after second LOC. Patient disoriented - is able to say why he is there and what his name was but cannot remember his age. EMS arrives and takes over care. EMS assessed patient and recommended to transport patient to ED for further assessment. Patient refuses transport to the hospital. EMS squad waits with patient until family member arrives. Patient states family member will transport to hospital. Patient leaves clinic site with family member in car.  First set of vitals/assessment after first LOC at 0940 142/96 BP; 74 pulse; 16 respirations; 97% spO2; 97.7 temp; PERRLA. No bleeding on head; scrape noted L elbow. EMS was called at 9:49am. EMS arrived at 9:54am.   Patient states no major medical history, not on any meds. Patient has fainted one time previously after broken thumb.
Fever, started 1 day after vaccination. Temperature 99.5F. Fatigue, generally assume to be baseline. Still feeling fatigue after 8-hour sleep in the morning.
He started having a bad headache about 7 hours after the shot.  The shot was administered at 2 pm E.S.T.  By morning he could not get up.  He said his whole body was sore with a headache, chills and low grade fever of 99.5.  He was bed ridden all day.  The next day was the same.  He was totally bedridden complaining that he couldn't bend the joints in his fingers all the way.  He said all of his body was sore.  He needed help going to the bathroom and back to bed.  The second night his respiratory rate was at 28-30 beats per minute with his heart pounding in his chest.  This now is the third day and we will be going in to the Drs. to find out what is going on.  His left upper arm where the shot was administered was extremely swollen looking like a large knot.
occipital headache started 1 day after vaccination, continues today (11/12/2021). headache made worse with speaking, ambulation and movement. Today reports neck pain/stiffness.
ACHINESS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had not participated in a clinical trial. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced achiness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from achiness. This report was non-serious.
vaccine given 17 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 17 days post expiry) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 17 days post expiry). On 23-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 17 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment information was reported.   This case was linked to MOD-2021-395985 (Patient Link).
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 15-MAR-2013, a healthcare provider administered ZOSTAVAX, (lot# and route unknown) to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. On or about September 2013, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. The patient used the ZOSTAVAX vaccine for the permanent prevention of shingles and zoster-related injuries. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Shot1: March  22 2021 severe injection site arm and shoulder pain  Shot 2:April 19 2021 severe injection site arm shoulder pain, flu- like illness for week.       July- recurring diverticulitis, mesenteric abscess culminating in colon resection 5/22      August- progressive left hand/ arm weakness.  shot 3: December 17, 2021 severe injection site injury, flu like illness week to 10 days, speech impairment begins followed by difficulty swallowing.
labeled expiration date was short dated to 1/30/2020 after a temperature excursion; labeled expiration date was short dated to 1/30/2020 after a temperature excursion; No adverse affects reported.; a dose of V ARIV AX was administered on 3/20/2020  after lhe labeled expiration date was short dated to 1/30/2020 after a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies was reported.   On 20-MAR-2020, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # S002396, expiration date reported as 31-JAN-2021, but upon internal validation established as 23-JAN-2021 (dose and route of administration were not provided) for prophylaxis.  It was reported that the labeled expiration date was short dated to 30-JAN-2020 due to a temperature excursion on an unknown date. The patient did not experience any additional adverse effects.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2005USA009775:
Immediately after receiving my first shot , I had noticed that I had an super fast irregular heart rhythm. This lasted for about 4 hrs after the shot, but was most noticed directly after the shot.  I did not say anything because I blew it off as me bei g nervous about the shot, but Im not really ever apprehensive or nervous during shots.  The exact same thing happened for the second shot,  little more intensely thi, but was ready for reaction so did not make fuss about it an did not contact nurse on duty or my doctor afterwards, but noticed that other people were having heart reactions with the Pfizer Vac, so thought should let you know about my reactions even tho molder than those reported.
Immunizations administered late pm 8/26/02. No symptoms Monday night and no complaints from child. On 8/27/02 am c/o arm (R) hurting-mother checked (R) upper arm-slightly warm to touch and some redness. Mother gave Motrin for temp 101 am child went to school; 8/27/02 post school larger area of redness but no hardness then. Gave Motrin for temp 100.9 degrees. 8/28/02 am-upper arm hard and red, saw MD-to use warm compresses, return on 8/30/02. Did not return to MD on 8/30/02 and unable to contact by # on record.
Fever started 10/21/07, vomited once, fever 103.8 on 10/22/07 - sore throat, hoarse, faint, pink rash around neck and cheeks.
This child had scattered vesicular lesions with red base, a few on the trunk, less than 20 lesions. Brea through varicella / had vaccine.
Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022; Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2022 at 1:02 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Feb-2022 at 1:02 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.   No treatment medication was reported.
Within 24 hours, post vax, pt developed speckly rash on trunk and fever of 102.
about 4 hours after shot given developed severe pain in upper right arm - felt like it was deep in the shoulder joint - had no range of motion whatsoever without intense pain - unable to use arm for 2 days(pain same as 1st day) - took tylenol and ibuprofin but did not help pain - 3rd day pain was less by about 40%-50% with very limited range of motion - 4th day same as 3rd - 5th day pain was better but saw primary care doctor for exam of arm - range of motion better but still feels stiff and more pain when certain motions attempted
A few hours after injection  patient reported she noticed some itching and a small lump around injection site.  Later that evening there was also some redness around the area.  The next day patient the lump had disappeared and the redness/heat had moved down and around the back of the arm .  The patient contacted her physician and he determined a local reaction to injection but gave patient a prescription for cephalexin (in case of cellulitis with instructions to only take if redness worsened).  Physician also instructed patient to take acetaminophen and use ice as needed.  Patient followed up with pharmacy two days later to report that heat had disappeared the redness was improved but had moved to front of arm in between injection site and elbow.  Patient stated she had not taken the antibiotics and would continue with acetaminophen as needed.
patient developed instant itch in throat after administration of vaccine  25mg PO Benadryl was given  reassessment 5 minutes later throat itchy, denies wheezing or SOB. Additional 25mg PO Benadryl was given  Patient devloped SOB, Epi pen adminstered 10:04am. EMS called for transport. SOB improved. Vital remained stable. EMS arrived and transported patient to hospital.
Pt recvd 1st dose of Hep B vax on 28FEB92; The next day pt exp severe abdo cramping; on 2MAR92 devel diarrhea; pt recovered the next day; No further details were provided;
"COVID arm". Soreness, dark bruising at injection site in first days after booster. Followed by lingering and constant dull to sharp aching and lower arm area below injection site. Certain movements created sharp pain. Deep and painful constant ache continued for months. Now it is a dull ache, but much exasperated by common things such as sleeping on left side/arm. Pain causes me to wake up and it lingers while I try to sleep, thus it has affected my sleep.
Bone pain and internal organ pain. Severe pain in kidney and ovary areas. When the standard side effects went away (body aches, fever, headache, etc.) the internal organ pain is lingering around 2 days post 2nd covid vaccine shot.
Swelling at the injection site, hives around the neck. Patient came in to the doctor's office again for a follow-up appointment on 07/24/2019 and the pt claimed the symptoms still present but are improving.